Do vervets and macaques respond differently to BMAA?

Paul Alan Cox, David A. Davis, Deborah C Mash, James S. Metcalf, Sandra Anne Banack

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Vervets with chronic dietary exposure to BMAA develop neurofibrillary tangles (NFT) and sparse β-amyloid plaque-like deposits in the brain. Macaques dosed via oral gavage with BMAA developed marked neurological signs in the absence of cell death. These differences may result from increased vulnerability of macaques to BMAA, the higher effective dose they received via oral gavage, and the possibility of stable adducts due to the bicarbonate used to neutralize their BMAA dose. Confirmation of chromatolysis and cell death in macaque brains was visualized using toluidine staining. In contrast, immunological staining with AT8 and β-amyloid (1-42) antibodies and thioflavine-S stain in vervet brains suggests early stage labeling of neurites and NFT and plaque-like formation in the absence of neuronal loss. The lack of neurologic deficits reported in vervets is in keeping with early preclinical pathology observed with these immunohistochemical methods. BMAA toxicity in vervet brains causes the early events that occur in the genesis of neurofibrillary pathology. Taken together, these different studies of vervets and macaques demonstrate BMAA toxicity in the brain due to chronic exposures. The use of more sensitive immunohistochemical methods in the vervet study most likely explains the differences in neuropathology reported for vervets and macaques.

Original languageEnglish (US)
JournalNeuroToxicology
DOIs
StateAccepted/In press - 2016

Fingerprint

Macaca
Brain
Neurofibrillary Tangles
Pathology
Cell death
Amyloid
Toxicity
Cell Death
Toluidines
Staining and Labeling
Amyloid Plaques
Neurites
Bicarbonates
Neurologic Manifestations
Labeling
Coloring Agents
Deposits
Antibodies

Keywords

  • Beta-amyloid
  • BMAA
  • Hyperphosphorylation
  • Macaques
  • Neurofibrillary tangles
  • Neuropathology
  • Thioflavin
  • Vervets

ASJC Scopus subject areas

  • Neuroscience(all)
  • Toxicology

Cite this

Cox, P. A., Davis, D. A., Mash, D. C., Metcalf, J. S., & Banack, S. A. (Accepted/In press). Do vervets and macaques respond differently to BMAA? NeuroToxicology. https://doi.org/10.1016/j.neuro.2016.04.017

Do vervets and macaques respond differently to BMAA? / Cox, Paul Alan; Davis, David A.; Mash, Deborah C; Metcalf, James S.; Banack, Sandra Anne.

In: NeuroToxicology, 2016.

Research output: Contribution to journalArticle

Cox, Paul Alan ; Davis, David A. ; Mash, Deborah C ; Metcalf, James S. ; Banack, Sandra Anne. / Do vervets and macaques respond differently to BMAA?. In: NeuroToxicology. 2016.
@article{5d312666b16945fca6fb39f6f7e20d06,
title = "Do vervets and macaques respond differently to BMAA?",
abstract = "Vervets with chronic dietary exposure to BMAA develop neurofibrillary tangles (NFT) and sparse β-amyloid plaque-like deposits in the brain. Macaques dosed via oral gavage with BMAA developed marked neurological signs in the absence of cell death. These differences may result from increased vulnerability of macaques to BMAA, the higher effective dose they received via oral gavage, and the possibility of stable adducts due to the bicarbonate used to neutralize their BMAA dose. Confirmation of chromatolysis and cell death in macaque brains was visualized using toluidine staining. In contrast, immunological staining with AT8 and β-amyloid (1-42) antibodies and thioflavine-S stain in vervet brains suggests early stage labeling of neurites and NFT and plaque-like formation in the absence of neuronal loss. The lack of neurologic deficits reported in vervets is in keeping with early preclinical pathology observed with these immunohistochemical methods. BMAA toxicity in vervet brains causes the early events that occur in the genesis of neurofibrillary pathology. Taken together, these different studies of vervets and macaques demonstrate BMAA toxicity in the brain due to chronic exposures. The use of more sensitive immunohistochemical methods in the vervet study most likely explains the differences in neuropathology reported for vervets and macaques.",
keywords = "Beta-amyloid, BMAA, Hyperphosphorylation, Macaques, Neurofibrillary tangles, Neuropathology, Thioflavin, Vervets",
author = "Cox, {Paul Alan} and Davis, {David A.} and Mash, {Deborah C} and Metcalf, {James S.} and Banack, {Sandra Anne}",
year = "2016",
doi = "10.1016/j.neuro.2016.04.017",
language = "English (US)",
journal = "NeuroToxicology",
issn = "0161-813X",
publisher = "Elsevier",

}

TY - JOUR

T1 - Do vervets and macaques respond differently to BMAA?

AU - Cox, Paul Alan

AU - Davis, David A.

AU - Mash, Deborah C

AU - Metcalf, James S.

AU - Banack, Sandra Anne

PY - 2016

Y1 - 2016

N2 - Vervets with chronic dietary exposure to BMAA develop neurofibrillary tangles (NFT) and sparse β-amyloid plaque-like deposits in the brain. Macaques dosed via oral gavage with BMAA developed marked neurological signs in the absence of cell death. These differences may result from increased vulnerability of macaques to BMAA, the higher effective dose they received via oral gavage, and the possibility of stable adducts due to the bicarbonate used to neutralize their BMAA dose. Confirmation of chromatolysis and cell death in macaque brains was visualized using toluidine staining. In contrast, immunological staining with AT8 and β-amyloid (1-42) antibodies and thioflavine-S stain in vervet brains suggests early stage labeling of neurites and NFT and plaque-like formation in the absence of neuronal loss. The lack of neurologic deficits reported in vervets is in keeping with early preclinical pathology observed with these immunohistochemical methods. BMAA toxicity in vervet brains causes the early events that occur in the genesis of neurofibrillary pathology. Taken together, these different studies of vervets and macaques demonstrate BMAA toxicity in the brain due to chronic exposures. The use of more sensitive immunohistochemical methods in the vervet study most likely explains the differences in neuropathology reported for vervets and macaques.

AB - Vervets with chronic dietary exposure to BMAA develop neurofibrillary tangles (NFT) and sparse β-amyloid plaque-like deposits in the brain. Macaques dosed via oral gavage with BMAA developed marked neurological signs in the absence of cell death. These differences may result from increased vulnerability of macaques to BMAA, the higher effective dose they received via oral gavage, and the possibility of stable adducts due to the bicarbonate used to neutralize their BMAA dose. Confirmation of chromatolysis and cell death in macaque brains was visualized using toluidine staining. In contrast, immunological staining with AT8 and β-amyloid (1-42) antibodies and thioflavine-S stain in vervet brains suggests early stage labeling of neurites and NFT and plaque-like formation in the absence of neuronal loss. The lack of neurologic deficits reported in vervets is in keeping with early preclinical pathology observed with these immunohistochemical methods. BMAA toxicity in vervet brains causes the early events that occur in the genesis of neurofibrillary pathology. Taken together, these different studies of vervets and macaques demonstrate BMAA toxicity in the brain due to chronic exposures. The use of more sensitive immunohistochemical methods in the vervet study most likely explains the differences in neuropathology reported for vervets and macaques.

KW - Beta-amyloid

KW - BMAA

KW - Hyperphosphorylation

KW - Macaques

KW - Neurofibrillary tangles

KW - Neuropathology

KW - Thioflavin

KW - Vervets

UR - http://www.scopus.com/inward/record.url?scp=84965031887&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84965031887&partnerID=8YFLogxK

U2 - 10.1016/j.neuro.2016.04.017

DO - 10.1016/j.neuro.2016.04.017

M3 - Article

C2 - 27133441

AN - SCOPUS:84965031887

JO - NeuroToxicology

JF - NeuroToxicology

SN - 0161-813X

ER -